[1] Borgwardt L, Hjgaard L, Carstensen H, et al. Increased fluorine-182-fluoro-2-deoxy-D-glucose(FDG) uptake in childhood CNS tumors is correlated with malignancy grade:a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion[J]. J Clin Oncol, 2005, 23(13):3030-3037.
[2] Utriainen M, Mets honkala L, Salmi TT, et al. Metabolic characterization of childhood brain tumors:comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography[J]. Cancer, 2002, 95(6):1376-1386.
[3] Hoffman JM, Hanson MW, Friedman HS, et al. FDG-PET in pediatric posterior fossa brain tumors[J]. J Comput Assist Tomogr, 1992, 16(1):62-68.
[4] Kwon JW, Kim IO, Cheon JE, et al. Paediatric brain-stem gliomas:MRI, FDG-PET and histological grading correlation[J]. Pediatr Radiol, 2006, 36(9):959-964.
[5] Pirotte B, Goldman S, Salzberg S, et al. Combined positron emission tomography and magnetic resonance imaging for the planning of stereotactic brain biopsies in children:experience in 9 cases[J]. Pediatr Neurosurg, 2003, 38(3):146-155.
[6] Messing-Junger AM, Floeth FW, Pauleit D, et al. Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas[J]. Childs Nerv Syst, 2002, 18(8):445-449.
[7] Pirotte B, Goldman S, Van Bogaert P, et al. Integration of[11C] methionine-positron emission tomographic and magnetic resonance imaging for image-guided surgical resection of infiltrative low-grade brain tumors in children[J]. Neurosurgery, 2005, 57(1 Suppl):128-139.
[8] Pirotte B, Levivier M, Morelli D, et al. Positron emission tomography for the early postsurgical evaluation of pediatric brain tumors[J]. Childs Nerv Syst, 2005, 21(4):294-300.
[9] Beuthien-Baumann B, Hahn G, Winkler C, et al. Differentiation between recurrent tumor and radiation necrosis in a child with anaplastic ependymoma after chemotherapy and radiation therapy[J]. Strahlenther Onkol, 2003, 179(12):819-822.
[10] Fenton LZ, Madden JR, Foreman NK. Brain stem glioma in a child:false diagnosis of radiation necrosis with FDG PET[J]. Med Pediatr Oncol, 2003, 40(4):260-262.
[11] Gururangan S, Hwang E, Hemdon JE, et al. 18F-Fluorodeoxyglucose positron emission tomography in patients with medulloblastoma[J]. Neurosurgery, 2004, 55(6):1280-1289.
[12] Holthoff VA, Herholz K, Berthold F, et al. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment[J]. Cancer, 1993, 72(4):1394-1403.
[13] Jadvar H, Connolly LP, Fahey FH, et al. PET and PET/CT in pediatric oncology[J]. Semin Nucl Med, 2007, 37(5):316-331.
[14] Ruotsalainen U, Suhonen-Povli H, Eronen E, et al. Estimated radiation dose to the newborn in FDG-PET studies[J]. J Nucl Med, 1996, 37(2):387-393.
[15] Schelbert H, Hoh CK, Royal HD, et al. Procedure guideline for tumor imaging using Fluorine-18-FDG[J]. J Nucl Med, 1998, 39(7):1302-1305.
[16] Bartenstein P, Asenbaum S, Catafau A, et al. European association of nuclear medicine procedure guidelines for brain imaging using[(18)F]FDG[J]. Eur J Nucl ned nol Imaging, 2002, 29(10):BP43-BP48.